Constance M. Cultraro

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer”.

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100007

N/A

5.6DataRank · unranked

182 citations

Anna‐Leigh Brown, Jun S. Wei, Svetlana Pack, Christopher Trindade, Chul Kim +26 more

Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance

Cancer Research(2021)10.1158/0008-5472.can-20-2435

N/A

0.633DataRank · unranked

67 citations

Tapan K. Maity, Karen Ross, Yue Qi, Constance M. Cultraro, Meriam Bahta +9 more

Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.04.236331

N/A

0DataRank · unranked

3 citations

Tapan K. Maity, Constance M. Cultraro, Vikram Misra, Xu Zhang, Catherine M. Ade +10 more

Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma

Molecular & Cellular Proteomics(2021)10.1016/j.mcpro.2021.100136

N/A

0DataRank · unranked

34 citations

Tapan K. Maity, Constance M. Cultraro, Vikram Misra, Xu Zhang, Catherine M. Ade +10 more

SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma

Oncogene(2021)10.1038/s41388-021-01764-y

N/A

0DataRank · unranked

13 citations

Matthew Lynberg, Constance M. Cultraro, Khoa Dang P. Nguyen, Xu Zhang, Maryam Waris +5 more

LKB1 acts as a critical brake for the glucagon‐mediated fasting response

Hepatology Communications(2022)10.1002/hep4.1942

N/A

0DataRank · unranked

7 citations

Megan Stefkovich, Sun Woo Sophie Kang, Rory P. Cunningham, Constance M. Cultraro, Natalie Porat‐Shliom +1 more

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance

Cancers(2023)10.3390/cancers15082263

N/A

0DataRank · unranked

9 citations

Eun Young Kim, Constance M. Cultraro, Abhilash Venugopalan, Leena Khare, Ramulu Poddutoori +7 more

Data from Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance

(2023)10.1158/0008-5472.c.6513445.v1

N/A

0DataRank · unranked

0 citations

Tapan Kumar Maity, Karen Ross, Qi Yue, Constance M. Cultraro, Meriam Bahta +9 more

A spatial map of hepatic mitochondria uncovers functional heterogeneity shaped by nutrient-sensing signaling

Nature Communications(2024)10.1038/s41467-024-45751-9

N/A

0DataRank · unranked

58 citations

Rory P. Cunningham, Colin B. Miller, Lauryn A. Brown, Constance M. Cultraro, Adam Harned +7 more

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0321

N/A

0DataRank · unranked

4 citations

Rajaâ El Meskini, Tapan K. Maity, Devon Atkinson, Amanda Day, Nathan Pate +6 more

Global proteome and phosphoproteome alterations in third generation EGFR TKI resistance reveal drug targets to circumvent resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.04.187617

N/A

0DataRank · unranked

3 citations

Tapan K. Maity, Karen Ross, Yue Qi, Constance M. Cultraro, Shaojian Gao +6 more